3 results
Approved WMOCompleted
The key objective of this study is to assess next-day residual effects of MK-4305 (20 and 40 mg) via driving performance after 1 day of dosing and after 8 days of dosing.
Approved WMOCompleted
Objective: The aim of this study is to evaluate if an adequate level of bowel cleansing can be achieved with the Pure-Vu in patients with previous poor bowel preparation (Boston Bowel Preparation Scale [BBPS]<6).
Approved WMOPending
To assess the sensitivity and specificity of optical spectroscopy for the detection of Invasive Ductal Carcinoma (IDC) and Ductal Carcinoma In Situ (DCIS) deposits on resection margins during breast conserving surgery.